Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.

It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.

If you have any feedback on the new format please contact the Project Manager for this appraisal.

Thrombocytopenic purpura - eltrombopag (rev TA205): evaluation report

01. NICE’s response to comments on the Appraisal Consultation Document (ACD)

02. Consultee comments on the ACD - GlaxoSmithKline

03. Consultee comments on the ACD - ITP Support Association

04. Consultee comments on the ACD - Royal College of Pathologists

05. Commentator comments on the ACD - Amgen

06. Public comments on the ACD received via the NICE website